Actelion Pharmaceuticals (VALCHLOR®)
Actelion has established VALCHLOR Support(TM), an assistance program to help eligible patients successfully start and remain on VALCHLOR (mechlorethamine) therapy. The program includes reimbursement and financial support for eligible patients, as well as disease and product information. VALCHLOR is only available through specialty pharmacies.
Visit www.valchlor.com for details about how to fill VALCHLOR prescriptions, insurance coverage and financial assistance.
For questions about your prescription, please call 1-855-482-5245. VALCHLOR representatives are available to help you Monday through Friday from 8am - 8pm (EST).
Spectrum Pharmaceuticals (FOLOTYN®)
Spectrum Therapy Access Resources (STAR®) is a reimbursement support, co-pay assistance, and patient assistance program designed to help patients and healthcare professionals in the United States gain appropriate access to Spectrum products. For more information visit www.SpectrumPatientAccess.com or call 888-537-8277.
Celgene Corporation (ISTODAX®)
Celgene Corporation, manufacturer of ISTODAX®, a drug used to treat cutaneous T-cell lymphoma and peripheral T-cell lymphoma, offers extensive patient support services through the Celgene Patient Support® program. This program provides a dedicated, central point of contact for patients and healthcare professionals who use Celgene products. The Celgene Patient Support® program is a free service that helps patients and healthcare professionals navigate the challenges of reimbursement, providing information about co-pay assistance, and answering questions about obtaining Celgene products. For assistance, call Celgene Patient Support® at 800.931.8691 or visit www.CelgenePatientSupport.com.
Sometimes, affording prescription medicines can be difficult. That’s why Merck has created the Patient Assistance Program—to keep affordable medicines within your reach. This private and confidential program provides medicine free of charge to eligible individuals, primarily the uninsured who, without our assistance, could not afford needed Merck medicines. Individuals who don’t meet the insurance criteria may still qualify for the Merck Patient Assistance Program if they attest that they have special circumstances of financial and medical hardship, and their income meets the program criteria. A single application may provide for up to one year of medicine free of charge to eligible individuals and an individual may reapply as many times as needed. For more information, visit www.merck.com/merckhelps/patientassistance/home.html or contact 800.727.5400.
Therakos (Photopheresis Therapy)
The THERAKOS® Photopheresis Patient Support Program provides a safety net of support for patients who cannot afford their prescribed therapy. It also serves as a central point of communication and coordination so that therapy may be initiated as soon as possible, and patients and caregivers are engaged and informed at every step along the way. This program is administered for Therakos, Inc. by the National Organization for Rare Disorders (NORD), a non-profit organization that has been serving the rare disease community with distinction for more than 30 years.
The THERAKOS® Photopheresis Patient Support Program is available to patients who do not have public or private prescription drug coverage and who meet income and eligibility guidelines. NORD is responsible for making all determinations of patient eligibility under this program. To learn more about the Therakos Patient Support Program, visit NORD’s website at www.rarediseases.org or call: 1-877-241-7220, Monday – Friday, 9:00am to 5:00pm EST.
Valeant Pharmaceuticals (Targretin®)
Valeant Pharmaceuticals has introduced the Targretin® Patient Care Program. This program assists with the complex financial coordination Targretin Capsules or Targretin Gel can require and provides patient follow-up to encourage therapy adherence. With the new rebate program, eligible commercially insured patients’ co-pays are no more than $20. For more information, visit www.targretin.com or call 888.479.6337.
CancerCare Co-Payment Assistance Foundation
The CancerCare Co-Pay Assistance Foundation is a nonprofit organization established in 2007 to address the needs of individuals who cannot afford their insurance co-payments to cover the cost of medications for treating cancer. For more information, contact 866.55.COPAY (2-6729), 212.601.9750 or firstname.lastname@example.org.
Chronic Disease Fund
The Chronic Disease Fund is an independent nonprofit charitable organization helping patients with chronic disease, cancers or life-altering conditions obtain the expensive medications they need. They assist patients throughout the United States who meet income qualification guidelines and/or have private insurance or a Medicare Part D plan but cannot afford the cost of their specialty therapeutics. For more information, visit www.cdfund.org or contact 877.968.7233.
Free Medicine Program
The Free Medicine Program offers free drugs. For more information, visit www.freemedicineprogram.com.
The HealthWell Foundation is a nonprofit organization committed to addressing the needs of individuals with insurance who cannot afford their copayments, coinsurance, and premiums for important medical treatments. Their vision is to ensure that no patient goes without health care because they cannot afford it. For more information, contact 800.675.8416 or visit www.healthwellfoundation.org.
Home Phototherapy Units
If a doctor has determined that phototherapy is the treatment of choice for your condition, a home unit may be an option. Click here to learn more.
The Medicine Program is a patient advocate organization with a goal of assisting you and your family find, apply and qualify for the right patient assistance program(s) offered by pharmaceutical companies. By working closely with you, your doctor and the drug manufacturer, the Medicine Program helps cut through the red tape and assists you in receiving your medicine free of charge. Visit www.themedicineprogram.com for more information.
National Organization for Rare Disorders
The National Organization for Rare Disorders (NORD) has a co-payment assistance program for people with peripheral T-cell lymphoma. For more information, visit www.rarediseases.org or call 202.588.5700.
NeedyMeds.org is a helpful resource to use for finding information about many drug assistance programs offered by states, localities and pharmaceutical manufacturers. Visit www.needymeds.org or contact 800.503.6897 for more information.
Partnership for Prescription Assistance
The Partnership for Prescription Assistance is a website hosted by pharmaceutical companies, physicians and patient advocacy groups that offers access to public and private patient assistance programs including more than 150 programs offered by pharmaceutical companies. For more information, visit www.pparx.org or contact 888.477.2669.
Patient Services, Inc.
Patient Services, Inc. (PSI) offers a cutaneous T-cell lymphoma co-pay assistance program that is designed to help those eligible afford the cost of their expensive prescription medication (oral and topical). To apply, call a PSI customer service representative at 800.366.7741 or visit www.patientservicesinc.org.
Pharmaceutical Research and Manufacturers of America
Some free or reduced-cost drugs are available through the Pharmaceutical Research and Manufacturers of America (PhRMA). Representing research-based pharmaceutical and biotechnology companies, PhRMA provides a Patient Assistance Directory on their web site, which is searchable by drug name or company. Visit www.phrma.org for more information.
RxOutreach has a number of very common generic drugs available at a low cost. Visit their website for a list of the drugs, application forms and other information about the program. For more information, contact 800.769.3880 or visit www.rxoutreach.com.
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.